BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 117 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $69 | -82.6% | 13,548 | -79.5% | 0.00% | -100.0% |
| Q4 2023 | $397 | +170.1% | 66,223 | +417.7% | 0.00% | +100.0% |
| Q4 2022 | $147 | -99.9% | 12,791 | -40.3% | 0.00% | -33.3% |
| Q3 2022 | $270,000 | -69.4% | 21,432 | -74.3% | 0.00% | -66.7% |
| Q2 2022 | $881,000 | -77.1% | 83,282 | -64.8% | 0.01% | -67.9% |
| Q1 2022 | $3,851,000 | +4.4% | 236,845 | -11.0% | 0.03% | +40.0% |
| Q4 2021 | $3,687,000 | -23.3% | 266,215 | -20.4% | 0.02% | -13.0% |
| Q3 2021 | $4,805,000 | +2866.0% | 334,378 | +3166.7% | 0.02% | +2200.0% |
| Q2 2021 | $162,000 | -76.8% | 10,236 | -85.1% | 0.00% | -75.0% |
| Q1 2021 | $697,000 | +61.0% | 68,533 | +18.0% | 0.00% | +100.0% |
| Q4 2020 | $433,000 | -40.3% | 58,085 | -72.5% | 0.00% | -60.0% |
| Q3 2020 | $725,000 | -83.7% | 211,071 | -77.4% | 0.01% | -86.5% |
| Q2 2020 | $4,455,000 | +3464.0% | 934,948 | +1399.6% | 0.04% | +3600.0% |
| Q1 2020 | $125,000 | +78.6% | 62,346 | +208.6% | 0.00% | 0.0% |
| Q4 2019 | $70,000 | -58.6% | 20,200 | -2.6% | 0.00% | -50.0% |
| Q1 2019 | $169,000 | +19.9% | 20,744 | -23.1% | 0.00% | +100.0% |
| Q3 2017 | $141,000 | +85.5% | 26,990 | +98.6% | 0.00% | 0.0% |
| Q2 2017 | $76,000 | -25.5% | 13,588 | +11.8% | 0.00% | 0.0% |
| Q1 2017 | $102,000 | -44.3% | 12,152 | -58.1% | 0.00% | -50.0% |
| Q4 2016 | $183,000 | +221.1% | 28,983 | +43.8% | 0.00% | – |
| Q1 2016 | $57,000 | -52.5% | 20,154 | +151.0% | 0.00% | -100.0% |
| Q2 2015 | $120,000 | -46.7% | 8,031 | -56.5% | 0.00% | 0.0% |
| Q4 2014 | $225,000 | +70.5% | 18,483 | +78.3% | 0.00% | 0.0% |
| Q2 2014 | $132,000 | +22.2% | 10,369 | +1.6% | 0.00% | – |
| Q1 2014 | $108,000 | +217.6% | 10,207 | -53.3% | 0.00% | – |
| Q2 2013 | $34,000 | – | 21,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |